Biophytis S.A. is a biotechnology company focused on developing drugs for the treatment of age-related diseases and muscle failure. Their main drug candidates include medicines for the treatment of sarcopenia and other age-related conditions such as Duchenne muscular dystrophy and age-related muscle weakness. Biophytis focuses on utilizing biopharmaceutical technologies and expertise in the physiology of aging to discover new therapeutic options. The company also conducts clinical trials to assess the efficacy and safety of its medicinal products. Biophytis S.A. shares could be suitable for investors looking for opportunities in the biotechnology sector with a focus on the treatment of age-related diseases and muscle failure.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
